Legal Proceedings Report • Jul 18, 2005
Legal Proceedings Report
Open in ViewerOpens in native device viewer
| C004 | אקס טי אל ביופרמסוטיקלס בע"מ | 2 | |
| Public | X T L BIOPHARMACEUTICALS LTD | ||
| 4312 | Corporation no: 520039470 | ||
| Stock Exchange/Market: אקס טי אל | |||
| 1996 | |||
| 352 | Hasapir 3 , Nes Ziona 76100 , , | ||
| Tel: 08-9304444 , Fax: 08-9304445 | |||
| E.mail address: [email protected] | Date of transmission: 18/07/2005 | ||
| Time of broadcast: 10:57 10:56:36 | |||
| Reference: 2005-02-054570 | |||
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Immediate report on other matterDon't use this form if there is more adequate one
| XTLbio Receives Fast Track Designation for Hepatitis C Therapy from US FDA |
| Attached file PRESS.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous name of reporting entity: XENOGRAFT TECHNOLOGIES LTD |
| Date of revision of form structure: 11/07/2005 |
| - - - |
| Name of the Signatory : Burgin Jonathan , , Position of Signatory in the reporting corporation: Chief Financial Officer |
| Hasapir Telephone: 08-9304440 , Facsimile: 08-9300659 , E-mail: [email protected] |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.